Clinical Trial

The RIPPLE AT-PLUS Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 25, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
Atrial tachycardia is a symptomatic arrhythmia, for which an effective treatment is a catheter ablation procedure. The goal of the Ripple AT-Plus study is to evaluate two methods of performing catheter ablation for atrial tachycardia. The main outcome assessed during the study is long-term recurrence of atrial tachycardia following the catheter ablation procedure.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2019-04-12; most recent amendment 2025-09-22.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-09-22
Status change: Recruiting → Not Yet Recruiting 2022-09-02
Status change: Not Yet Recruiting → Recruiting 2020-07-30
Trial Details
NCT Number NCT03915691
Lead Sponsor Liverpool Heart and Chest Hospital NHS Foundation Trust
Collaborators: Imperial College Healthcare NHS Trust, Norfolk & Norwich University Hospital Trust, Nottingham University Hospitals NHS Trust, University Hospital Plymouth NHS Trust, Blackpool Teaching Hospitals NHS Trust, Cardiff & Vale UHB, University Hospitals Sussex NHS Foundation Trust
Conditions Atrial Tachycardia
Enrollment 201 participants
Start Date 2022-08-16
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2025-09-25